# Measuring Brain Inflammation in Autism

> **NCT03117530** · PHASE1 · SUSPENDED · sponsor: **University of California, Los Angeles** · enrollment: 30 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT03117530
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-04-11
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** COVID
- **Last updated:** 2020-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117530, "Measuring Brain Inflammation in Autism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03117530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*